Chargement en cours...
A systematic review and combined meta‐analysis of concentration of oral amisulpride
AIMS: Amisulpride, a first‐line schizophrenia treatment, has shown large interindividual variability in plasma/serum levels, often outside the reference range (100–320 ng/mL). This study aims to clarify the impact of dose, sex, age and related factors for the interpatient variability in amisulpride...
Enregistré dans:
| Publié dans: | Br J Clin Pharmacol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7098868/ https://ncbi.nlm.nih.gov/pubmed/32090363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14246 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|